Tower Research Capital LLC (Trc) Aptorum Group LTD Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.14 - $12.9 $435 - $4,927	-382 Reduced 12.28%	2,730 $3,000
Q2 2022 Aug 15, 2022	BUY	$0.95 - $1.67 $2,020 - $3,552	2,127 Added 215.94%	3,112 $4,000
Q1 2022 May 12, 2022	BUY	$1.22 - $2.28 $1,079 - $2,017	885 Added 885.0%	985 $2,000
Q4 2021 Feb 14, 2022	BUY	$1.5 - $2.64 $150 - $264	100 New	100 $0
Q3 2021 Nov 15, 2021	SELL	$2.39 - $3.22 $9,184 - $12,374	-3,843 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.37 - $3.43 $9,107 - $13,181	3,843 New	3,843 $12,000
Q3 2019 Nov 05, 2019	SELL	$15.0 - $24.49 $915 - $1,493	-61 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$13.3 - $32.55 $186 - $455	-14 Reduced 18.67%	61 $2,000
Q1 2019 May 14, 2019	BUY	$12.91 - $15.67 $968 - $1,175	75 New	75 $1,000

Ticker APM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,265,500
Market Cap $28.1M
Description
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.